Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Udenafil may help hair grow by activating certain stem cells.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Higher levels of a specific hormone are linked to more chest hair and acne in men.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

A neurosteroid can reduce caffeine-induced anxiety in rats.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The compounds tested could potentially treat hair loss and alopecia.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Dutasteride effectively treats enlarged prostate with manageable side effects.